Biosimilars drive Biocon’s Q1 revenue growth, net profit up at ₹141 cr

· thehindubusinessline.com

Biocon's Q1 revenue rises 10% to ₹4,336 crore, driven by a 355% net profit surge from its biosimilars business.

Biocon reported a 355 per cent year-on-year (y-o-y) increase in its net profit to ₹141 crore for the first quarter of FY27. Revenue rose 10 per cent y-o-y to ...


Read on WOBR AI → · More AI market news · StrategyVerse · Quant Research · WOBR.AI